Search for: "Lupin Limited"
Results 21 - 40
of 80
Sort by Relevance
|
Sort by Date
3 May 2015, 9:59 pm
Lupin Ltd. et al. 1:15-cv-03051; filed April 30, 2015 in the District Court of New Jersey • Plaintiffs: Horizon Pharma Ireland Ltd.; HZNP Limited; Horizon Pharma USA, Inc. [read post]
20 Mar 2015, 11:58 am
Lupin (Fed. [read post]
22 Apr 2014, 11:29 pm
Lupin, Ltd., 676 F.3d 1316,1319 (Fed. [read post]
22 Apr 2014, 11:51 am
Lupin Ltd., 2011 WL 1897322 (D. [read post]
8 Apr 2014, 10:01 pm
” NRDC recommends that FDA publish safety concerns even when companies withdraw notices, require that FDA be informed of GRAS determinations, and limit conflicts of interest. [read post]
28 Mar 2014, 5:33 pm
Id. at *8-9 (citations and internal quotation marks omitted).Disclosure of Limited Test Results Does Not Limit Claimed Compound"The plain language of the claim does not include the narrowing limitation that the Appellants desire. [read post]
1 Apr 2013, 8:29 am
.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
8 Mar 2013, 2:39 am
Also, with regard to the presumption created under Section 31, the court upholds the view taken in Marico Limited v. [read post]
20 Dec 2012, 8:44 am
Lupin Limited, et al., C.A. [read post]
21 Nov 2012, 11:32 am
Lupin Ltd., C.A. [read post]
12 Sep 2012, 2:41 am
The plaintiffs have filed the suit after receiving notification under paragraph IV[1] from Lupin Limited stating that Lupin had filed an ANDA (Abbreviated NDA) application to seek approval to market a generic version of APRISO®. [read post]
16 Aug 2012, 8:42 am
Lupin, Ltd., 499 F.3d 1293, 1302 (Fed. [read post]
2 Jul 2012, 9:37 pm
Lupin, No. 2012-1228 (Fed. [read post]
29 Jun 2012, 4:52 am
This includes the market reforms already in effect (e.g., adult child coverage; phase-in of annual/lifetime limits; and the [read post]
22 Feb 2012, 5:49 pm
Lupin, Ltd. et al. [read post]
3 Jan 2012, 8:15 am
And the fans of Arsène Lupin, the French ‘gentleman burglar’, are now able to borrow – for good! [read post]
7 Sep 2011, 4:22 am
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]
10 Aug 2011, 4:30 am
Lupin Ltd. et al. [read post]
3 Aug 2011, 3:31 am
422/10 Georgetown University v Comptroller-General of Patents, Designs and Trade Marks (The SPC Blog) France: Limitation of the French designation of a European patent: before which office? [read post]
1 Jun 2011, 5:51 pm
Karst – Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]
